First Sponsor Group Balance Sheet Health

Financial Health criteria checks 2/6

First Sponsor Group has a total shareholder equity of SGD2.1B and total debt of SGD1.3B, which brings its debt-to-equity ratio to 61.9%. Its total assets and total liabilities are SGD4.6B and SGD2.6B respectively. First Sponsor Group's EBIT is SGD54.5M making its interest coverage ratio 1.9. It has cash and short-term investments of SGD217.8M.

Key information

61.9%

Debt to equity ratio

S$1.29b

Debt

Interest coverage ratio	1.9x
Cash	S$217.76m
Equity	S$2.09b
Total liabilities	S$2.55b
Total assets	S$4.64b

Recent financial health updates

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

Oct 03

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

Jun 03

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Jan 24

Recent updates

First Sponsor Group's (SGX:ADN) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 09

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

Oct 03

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

Jun 03

One First Sponsor Group Limited (SGX:ADN) Analyst Is Reducing Their Forecasts For This Year

Apr 29

Financial Position Analysis

Short Term Liabilities: ADN's short term assets (SGD2.1B) exceed its short term liabilities (SGD1.4B).

Long Term Liabilities: ADN's short term assets (SGD2.1B) exceed its long term liabilities (SGD1.2B).

Debt to Equity History and Analysis

Debt Level: ADN's net debt to equity ratio (51.5%) is considered high.

Reducing Debt: ADN's debt to equity ratio has increased from 52.8% to 61.9% over the past 5 years.

Debt Coverage: ADN's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: ADN's interest payments on its debt are not well covered by EBIT (1.9x coverage).

First Sponsor Group Balance Sheet Health

Financial Health criteria checks 2/6

Key information

Recent financial health updates

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Recent updates

First Sponsor Group Limited Announces Retirement of Yee Chia Hsing as the Lead Independent Director and Non-Executive Director

First Sponsor Group's (SGX:ADN) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings released: EPS: S$0.013 (vs S$0.14 in FY 2022)

First Sponsor Group Limited, Annual General Meeting, Apr 25, 2024

High number of new directors

First Sponsor Group Limited Appoints Ms. Low Beng Lan as Independent Non-Executive Director

Non-Executive Chairman exercised options to buy S$944k worth of stock.

Full year 2023 earnings released: EPS: S$0.013 (vs S$0.14 in FY 2022)

First Sponsor Group Limited Proposes Final Cash Dividend for the Year Ended December 31, 2023, Payable on 27 May 2024

New minor risk - Financial data availability

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

New minor risk - Shareholder dilution

Upcoming dividend of S$0.011 per share at 3.1% yield

New major risk - Financial position

First Sponsor Group Limited Declares First Interim Tax-Exempt Dividend for the Financial Year Ending 31 December 2023, Payable on 2 October 2023

Upcoming dividend of S$0.027 per share at 3.0% yield

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Alternate Director recently bought S$132k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

First Sponsor Group Limited Proposes Final Dividend for the Financial Year Ended 31 December 2022 Paid on or Around 19 May 2023

Insufficient new directors

Price target decreased to S$1.39

Insufficient new directors

Insufficient new directors

First Sponsor Group Limited Appoints Mr. Frans Van Toor as Chief Executive Officer (European Office & Residential Operations)

First Sponsor Group Limited Announces Change of Singapore Business Office Address

Price target decreased to S$1.39

Insufficient new directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

First Sponsor Group Limited, Annual General Meeting, Apr 26, 2022

Insufficient new directors

Upcoming dividend of S$0.024 per share

Consensus forecasts updated

Group CEO & Executive Director exercised options to buy S$4.2m worth of stock.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

First Sponsor Group Limited Announces Second Interim Tax-Exempt (One-Tier) Dividend for the Financial Year Ended 31 December 2021, Payable on or About 1 April 2022

Upcoming dividend of S$0.011 per share

Alternate Director exercised options to buy S$932k worth of stock.

Non-Executive Chairman recently bought S$879k worth of stock

Consensus EPS estimates increase to S$0.11

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

One First Sponsor Group Limited (SGX:ADN) Analyst Is Reducing Their Forecasts For This Year

Full year 2020 earnings released: EPS S$0.12 (vs S$0.22 in FY 2019)

New 90-day high: S$1.39

Non-Executive Chairman recently bought S$274k worth of stock

First Sponsor Group Limited (SGX:ADN) entered into a conditional sale and purchase agreement to acquire Guangzhou Panyu Chuang's Real Estate Development Company Limited from Chuang's China Realty Limited for CNY 1.6 billion.

Full year 2020 earnings released: EPS S$0.12 (vs S$0.22 in FY 2019)

Revenue and earnings miss expectations

Upcoming Dividend of S$0.02 Per Share

New 90-day high: S$1.36

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Update: First Sponsor Group (SGX:ADN) Stock Gained 14% In The Last Five Years

First Sponsor Group (SGX:ADN) Is Growing Earnings But Are They A Good Guide?

Analysts lower revenue estimates to S$255.3m

Third quarter earnings released

New 90-day high - S$1.32

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies